
|Articles|September 24, 2018
- September 2018 Immunization
- Volume 84
- Issue 9
Improving Patients' Understanding of the Clinical Benefit of EPA and DHA Omega-3s
Author(s)David J. Foreman, RPh, ND
Advertisement
FACULTY
David J. Foreman, RPh, ND Author/Medical Expert Herbal Pharmacist Palm Harbor, Florida
EDUCATIONAL OBJECTIVES:
At the completion of this activity, the participant will be able to:
- Explain the mechanism and disease states in which omega-3 supplementation has been shown to have positive outcomes
- Identify the recommended dose of omega-3s for specific patients and disease states
- Examine and understand common barriers to patient utilization of omega-3 supplements
TARGET AUDIENCE: Retail pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: September 10, 2018
EXPIRATION DATE: September 10, 2019
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at
Articles in this issue
about 7 years ago
The Waiting Is the Hardest Partabout 7 years ago
New and Novel HIV Medicationsabout 7 years ago
Self-Care for Respiratory Issuesabout 7 years ago
States Continue to Expand Availability of Telehealthabout 7 years ago
Educating Patients About the Dangers of Sharing Rx Medicationsabout 7 years ago
When Complying With a Law Enforcement Request Causes Problemsabout 7 years ago
Pharmacists Play a Key Role in Counseling Patients About ProbioticsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
Early RSV Vaccine Uptake Among Older Adults Reveals Significant Access Gaps
4
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
5





































































































































































































